Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maise Al Bakir

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
British Medical Bulletin|December 5, 2014
The molecular genetics of hereditary and sporadic ovarian cancer: implications for the futureMaise Al Bakir, Hani Gabra
Annals of the New York Academy of Sciences|October 8, 2008
Circulating 11beta-hydroxysteroid dehydrogenase type 1 mRNA and cardiovascular risk factorsMaise Al Bakir, Asif N Butt, R Swaminathan
Ejhaem|October 17, 2024
Single-centre experience of implementing physiotherapist-led prehabilitation for chimeric antigen receptor T cell therapyOrla McCourt, Paul Maciocia, Claire Roddie, et al.
Cell|March 29, 2024
Cancer biomarkers: Emerging trends and clinical implications for personalized treatmentAntonio Passaro, Maise Al Bakir, Emily G Hamilton, et al.
Genome Research|February 19, 2026
Gene duplication is associated with gene diversification and potential neofunctionalization in lung cancer evolutionPaul Ashford, Alexander M Frankell, Zofia Piszka, et al.
Nature|September 9, 2021
Using DNA sequencing data to quantify T cell fraction and therapy responseRobert Bentham, Kevin Litchfield, Thomas B K Watkins, et al.
Nature Cancer|May 31, 2022
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancerYin Wu, Dhruva Biswas, Ieva Usaite, et al.
The Lancet. Oncology|July 12, 2017
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysisSamra Turajlic, Kevin Litchfield, Hang Xu, et al.
Nature Communications|August 1, 2020
Escape from nonsense-mediated decay associates with anti-tumor immunogenicityKevin Litchfield, James L Reading, Emilia L Lim, et al.
Nature Medicine|May 29, 2020
Geospatial immune variability illuminates differential evolution of lung adenocarcinomaKhalid AbdulJabbar, Shan E Ahmed Raza, Rachel Rosenthal, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
British Medical Bulletin|December 5, 2014
The molecular genetics of hereditary and sporadic ovarian cancer: implications for the futureMaise Al Bakir, Hani Gabra
Annals of the New York Academy of Sciences|October 8, 2008
Circulating 11beta-hydroxysteroid dehydrogenase type 1 mRNA and cardiovascular risk factorsMaise Al Bakir, Asif N Butt, R Swaminathan
Ejhaem|October 17, 2024
Single-centre experience of implementing physiotherapist-led prehabilitation for chimeric antigen receptor T cell therapyOrla McCourt, Paul Maciocia, Claire Roddie, et al.
Cell|March 29, 2024
Cancer biomarkers: Emerging trends and clinical implications for personalized treatmentAntonio Passaro, Maise Al Bakir, Emily G Hamilton, et al.
Genome Research|February 19, 2026
Gene duplication is associated with gene diversification and potential neofunctionalization in lung cancer evolutionPaul Ashford, Alexander M Frankell, Zofia Piszka, et al.
Nature|September 9, 2021
Using DNA sequencing data to quantify T cell fraction and therapy responseRobert Bentham, Kevin Litchfield, Thomas B K Watkins, et al.
Nature Cancer|May 31, 2022
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancerYin Wu, Dhruva Biswas, Ieva Usaite, et al.
The Lancet. Oncology|July 12, 2017
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysisSamra Turajlic, Kevin Litchfield, Hang Xu, et al.
Nature Communications|August 1, 2020
Escape from nonsense-mediated decay associates with anti-tumor immunogenicityKevin Litchfield, James L Reading, Emilia L Lim, et al.
Nature Medicine|May 29, 2020
Geospatial immune variability illuminates differential evolution of lung adenocarcinomaKhalid AbdulJabbar, Shan E Ahmed Raza, Rachel Rosenthal, et al.
Pageof 4